Yorktown Management & Research Company’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,600
Closed -$319K 213
2023
Q3
$319K Hold
4,600
0.36% 130
2023
Q2
$372K Hold
4,600
0.4% 114
2023
Q1
$371K Hold
4,600
0.4% 100
2022
Q4
$344K Buy
+4,600
New +$328K 0.42% 110
2022
Q3
Sell
-3,100
Closed -$215K 210
2022
Q2
$215K Buy
+3,100
New +$230K 0.28% 164

Other funds holding HOLX

Yorktown Management & Research Company's HOLX Position: Q4 2023 in Review

Yorktown Management & Research Company sold out of Hologic (HOLX) in Q4 2023, closing a stake of 4,600 shares — an estimated $319K sold.

Yorktown Management & Research Company first reported a position in HOLX in Q2 2022 and held it in 5 quarters. The position peaked at $372K in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Yorktown Management & Research Company reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Yorktown Management & Research Company sold 4,600 Hologic shares in Q4 2023, an estimated $319K.
  • Yorktown Management & Research Company first reported a position in Hologic in Q2 2022 and held it in 5 quarters.
  • Yorktown Management & Research Company's Hologic position peaked at $372K in Q2 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Yorktown Management & Research Company's 13F filing for Q4 2023, filed 26 Jan 2024.